Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Permanent Supportive Housing Overdose Prevention (POP) Study: A Hybrid Type 3 Stepped Wedge Randomized Controlled Trial

NCT05786222 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT05786222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05786222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Permanent Supportive Housing Overdose Prevention (POP) Study: A Hybrid Type 3 Stepped Wedge Randomized Controlled Trial
Lead sponsor
NYU Langone Health
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 26, 2023
Completion date
January 31, 2027
Enrollment
1,350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overdose